Interrogating the Genomic Landscape of Uterine Leiomyosarcoma: A Potential for Patient Benefit

SIMPLE SUMMARY: Uterine leiomyosarcoma is an aggressive and rare cancer that is difficult to treat. There are a number of mutations that are common to uterine leiomyosarcoma that are currently not routinely targeted therapeutically in this cancer type. In this review, we summarise the studies being...

Descripción completa

Detalles Bibliográficos
Autores principales: Dall, Genevieve V., Hamilton, Anne, Ratnayake, Gayanie, Scott, Clare, Barker, Holly
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8946513/
https://www.ncbi.nlm.nih.gov/pubmed/35326717
http://dx.doi.org/10.3390/cancers14061561

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8946513/
https://www.ncbi.nlm.nih.gov/pubmed/35326717
http://dx.doi.org/10.3390/cancers14061561

Ejemplares similares